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ABSTRACT: Precise control over the morphological features
of nanoparticles is an important requisite for their application
in nanomedical research. Parameters such as size and shape
have been identiﬁed as critical features for eﬀective nano-
therapeutic technologies due to their role in circulation,
distribution, and internalization in vivo. Tubular PEG−
PDLLA polymersomes (nanotubes) exhibit an interesting
morphology with potential for immunotherapeutics, as the
elongated shape can aﬀect cell−particle interactions. Devel-
oping methodologies that permit control over the precise form of such nanotubes is important for their biomedical
implementation due to the stringent physicochemical constraints for eﬃcacious performance. Through careful control over the
engineering process, we demonstrate the generation of well-deﬁned nanotubes based on polymersomes as small as 250 and 100
nm, which can be successfully shape transformed. The quality of the resulting nanostructures was established by physical
characterization using AF4-MALS and cryo-TEM. Moreover, we show the successful loading of such nanotubes with model
payloads (proteins and drugs). These ﬁndings provide a promising platform for implementation in biomedical applications in
which discrete structure and functionality are essential features.
■ INTRODUCTION
The development of therapeutic nanoparticles has progressed
beyond its early phase, during which challenges such as drug
solubilization and delivery were paramount to consider more
complex issues associated with morphology and speciﬁc
interactions with biological interfaces.1−4 The physicochemical
properties of nanotherapeutic technologies, including size,
shape, composition, and surface chemistry, are receiving
greater attention as the key determinants of eﬃcacy and safety
due to the inﬂuence of these parameters on blood circulation,
vascular penetration, biodistribution, cellular uptake, and
immunogenicity.5−10
Having identiﬁed that nanoparticles with a size ∼100 nm
demonstrate improved performance in terms of circulation
times and cellular uptake, the importance of size is a well-
established design parameter for nanomedicine.1,11,12 More
recently, the eﬀect of shape has fueled research for its potential
to further improve the eﬃcacy of nanoparticles.13−17 For
example, it has been demonstrated that nature-inspired
discoidal or tubular nanoparticles−having a comparable
morphology to disk-shaped red blood cells and rod-shaped
bacteria−are less susceptible to phagocytosis.10 This morpho-
logically induced stealth-like property was shown to reduce
adverse cardiopulmonary distress by avoiding clearance of the
intravenously administrated nanoparticles by pulmonary intra-
vascular macrophages (PIMs).5 Worm-like ﬁlomicelles,
morphologically equivalent to ﬁlamentous viruses, have also
been developed to exploit the long circulation and stealth-like
properties of elongated nanoparticles.18 Likewise, avoidance of
the monophagocytotic system (MPS) is a key advantage in
using such technology. Opposed to the previous examples,
where cellular interaction is avoided, nanoparticle size and
shape are also essential features to improve eﬀective surface
interaction for immunostimulation.12,19
In order to control the morphological features of nano-
particles, a number of strategies have been developed, such as
lithographic molding using the PRINT technology,20 mechan-
ical polymer ﬁlm-stretching21 and polymer-induced self-
assembly (PISA),22,23 which are extensively reviewed else-
where.7,10,24 Recently, our group has demonstrated that the
self-assembly of biodegradable block copolymers (BCPs) can
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provide a direct route toward the formation of polymersomal
architectures that can be shape transformed into both oblate
(discoidal or stomatosomal) and prolate (tubular) morphol-
ogies.25,26 This was achieved through careful molecular
engineering of the amphiphilic block copolymer poly(ethylene
glycol)-block-poly(D,L-lactide) (PEG−PDLLA) and its assem-
bly process. Parameters such as polymer chain length and
thickness of the surface PEG-layer were varied in order to
direct osmotically induced shape transformations toward
stomatocytes25 or nanotubes26 during dialysis of initially
spherical polymersomes. Specially, biodegradable PEG−
PDLLA polymersomes with tubular morphology have great
potential to provide a platform for nanomedicine applica-
tions.14,15 In particular, the engineering of these nanotubes into
artiﬁcial antigen presenting cells that can trigger speciﬁc
immune-activation is an exciting prospect.12,19,27,28 However, a
greater degree of control must be achieved before such a
system can be translated toward biomedical research due to the
importance of systematic reproducibility and of uniformity in
the aspect ratio of the resultant nanoparticles.
Here, we present the development of a robust approach for
the controlled fabrication of well-deﬁned nanotubes, based
upon polymersomes with an average size of ∼100 nm. After
preparation of small uniform polymersomes via physical
processing (extrusion), shape transformation into their prolate
counterparts could be realized eﬃciently, generating truly
nanotubular structures (Figure 1). Furthermore, using
asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) coupled with
multiangle light scattering (MALS) we present a robust
characterization methodology for such particles, where physical
measurement of hydrodynamic radius (Rh) and radius of
gyration (Rg) can be readily obtained and conﬁrmed by cryo-
transmission electron microscopy (TEM). This technology
now provides a robust platform for the generation of precision
nanomedical formulations with control over both size and
shape for applications such as immunotherapy and drug
delivery.
■ EXPERIMENTAL SECTION
Materials. All chemicals were used as received unless otherwise
stated. For the synthesis of poly(ethylene glycol)-b-poly(D,L-lactide)
(PEG−PDLLA), poly(ethylene glycol) 1K was purchased from
JenKem technology and lyophilized before use. D,L-Lactide was
purchased from Acros and used as supplied. DiD’ Solid (DiIC18(5)
solid (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine, 4-
chlorobenzenesulfonate salt) and Alexa Fluor 488 5-SDP Ester
(Alexa Fluor 488 sulfodichlorophenol ester) were purchased from
Thermo Fisher Scientiﬁc (Invitrogen). Albumin from bovine serum
(BSA) and sodium chloride were purchased from Merck. All other
chemicals were supplied by Merck and were used without any
puriﬁcation. For the polymersome self-assembly and dialysis,
ultrapure Milli-Q water was used, which was obtained from a
Merck Millipore Q-Pod system (18.2 MΩ) with a 0.22 μm Millipore
Express 40 ﬁlter. Dialysis membranes with a molecular weight cutoﬀ
(MWCO) of 12000−14000 Da from Spectra/Por were used for
dialysis during the formation of polymersomes and nanotubes.
Whatman Nuclepore track-etched membranes were purchased from
Merck and used for polymersome extrusion together with 10 mm
ﬁlter supports, purchased from Avanti Polar Lipids. Amicon Ultra 0.5
mL Centrifugal Filters 3K were purchased from Merck and used for
concentration of the polymersomes.
Instruments. Nuclear Magnetic Resonance (NMR). Proton
nuclear magnetic resonance measurements were performed on a
Bruker 400 Ultrashield spectrometer equipped with a Bruker
SampleCase autosampler, using CDCl3 as a solvent and TMS as an
internal standard.
Gel Permeation Chromatography (GPC). GPC was conducted
using a Shimadzu Prominence-i GPC system with a PL gel 5 μm
mixed D and mixed C column (Polymer Laboratories) with PS
standard and equipped with a Shimadzu RID-20A diﬀerential
refractive index detector and THF used as an eluent with a ﬂow
rate of 1 mL min−1.
Dynamic Light Scattering (DLS). DLS measurements were
performed on a Malvern instrument Zetasizer (model Nano ZSP)
equipped with an auto sampler. Zetasizer software was used to process
and analyze the data.
Cryogenic Transmission Electron Microscopy (cryo-TEM). Experi-
ments were performed using a FEI Tecnai G2 Sphere (200 kV
electron source) equipped with LaB6 ﬁlament utilizing a cryoholder
or a FEI Titan (300 kV electron source) equipped with autoloader
station. Samples for cryo-TEM were prepared by treating the grids
(Lacey carbon coated, R2/2, Cu, 200 mesh, EM sciences) in a
Cressington 208 carbon coater for 40 s. Then, 3 μL of the
polymersome solution was pipetted on the grid and blotted in a
Vitrobot MARK III at 100% humidity. The grid was blotted for 3 s
(oﬀset −3) and directly plunged and frozen in liquid ethane.
Processing of TEM images was performed with ImageJ, a program
developed by NIH and available as public domain software at http://
rsbweb.nih.gov/ij/. The nanotube aspect ratio was calculated by
dividing the measured length by the width of each tube and
calculating the mean value.
Asymmetric Flow Field-Flow Fractionation and Multiangle Light
Scattering (AF4-MALS). The Asymmetric Flow Field-Flow Fractio-
nation−UV−QELS (AF4-UV-QELS) measurements were performed
on a Wyatt Dualtec AF4 instrument connected to a Shimadzu LC-
2030 Prominence-i system with Shimadzu LC-2030 autosampler. The
AF4 was connected to Wyatt Optilab rEX refractive index detector
and Wyatt DAWN HELEOS II light scattering detector (MALS)
installed at diﬀerent angles (12.9°, 20.6°, 29.6°, 37.4°, 44.8°, 53.0°,
61.1°, 70.1°, 80.1°, 90.0°, 99.9°, 109.9°, 120.1°, 130.5°, 149.1°, and
157.8°). The MALS laser operated at 658 nm. Detectors were
normalized using Bovine Serum Albumin (BSA). The processing and
analysis of the light scattering data and radius of gyration (Rg)
calculations were performed on Astra 7 software. As particles were of
size >50 nm, the Berry model was used for analysis.29 All
fractionations were performed on an AF4 short channel equipped
with regenerated cellulose (RC), a 10 kDa membrane (Millipore),
and a spacer of 350 μm. The applied ﬂow conditions are indicated in
Table S1.
Confocal Microscopy. Confocal microscopy experiments were
performed using the Leica TCS SP5X system with a HCX PL Apo CS
63 × 1.20 Water UV objective and HyD detector, scanning at a speed
of 400 Hz. For imaging of BSA-AF488-loaded polymersomes
excitation at 490 nm and emission from 505 to 611.8 nm was used,
along with a 1 airy pinhole. For imaging of DiD-loaded polymersomes
excitation at 631 nm and emission from 650 to 750 nm was used,
along with a 1 airy pinhole.
Figure 1. Schematic outlining of the extrusion of PEG−PDLLA
polymersomes using (a) 400 and (b) 100 nm ﬁlters. Their osmotically
induced shape transformation results in well-deﬁned nanotubes (c)
and (d).
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Nanotube Puriﬁcation via Size Exclusion Chromatography
(SEC). SEC puriﬁcation of the loaded polymersomes and nanotubes
was conducted using a Shimadzu system (LC-20AD equipped with a
SPD-20A photodiode array) with a Superose 6 column (GE
Healthcare) using Milli-Q water as an eluent.
Fluorescence Spectroscopy. Fluorescence emission spectra of
polymersomes loaded with ﬂuorescent cargo were measured using the
Cary Eclipse ﬂuorescence spectrophotometer from Agilent. Diluted
polymersome samples, obtained after their puriﬁcation, were directly
measured. The BSA-AF488 ﬂuorescence emission spectrum was
obtained by excitation at 460 nm using a 20 nm slit and emission was
measured from 490 nm using a 20 nm slit. The DiD ﬂuorescence
emission spectrum was obtained by excitation at 600 nm using a 20
nm slit and emission was measured from 630 nm using a 10 nm slit.
■ METHODS
Preparation of PEG−PDLLA Polymersomes and Nanotubes.
The synthesis of block copolymer PEG22-PDLLA45 was performed
according to a previously described procedure (Supporting
Information, section 1.1). In a 15 mL glass vial, PEG22-PDLLA45
(20 mg) was weighed. To the block-co-polymer, 1.4 mL of dioxane
and 0.6 mL of THF (4:1 v/v) were added, and a magnetic stirrer bar
was added to the solution. Subsequently, the vial was capped with a
rubber septum and the solution was stirred for 30 min. Using a
syringe pump, 2 mL (50 vol %) of Milli-Q water was added at a rate
of 1 mL hr−1. The obtained cloudy polymersome solution was directly
transferred to a prehydrated dialysis membrane and dialysis was
performed at 4 °C against precooled Milli-Q water (1 L) over 24 h,
with a water change after 1 h. For the formation of nanotubes, the
polymersome solution was dialyzed against a 50 mM sodium chloride
solution.
Fabrication of Well-Deﬁned Spherical Polymersomes and
Nanotubes. In order to form well-deﬁned polymersomes, the
preparation procedure was slightly adjusted. Prior to dialysis, the
polymersome solution was extruded to obtain polymersomes with a
well-deﬁned size. To increase membrane ﬂexibility for extrusion, the
relative amount of organic solvent was therefore increased by only
adding 1 mL (33 vol %) of Milli-Q water at a rate of 1 mL hr−1. The
resulting polymersome solution was extruded by passing the solution
11 times through an Avanti Mini-Extruder, which was assembled with
a 100 nm polycarbonate membrane ﬁlter supported by two 10 mm
ﬁlter supports. The extruded polymersome solution was transferred to
a prehydrated dialysis membrane. To preserve the spherical
morphology of the resulting polymersomes, dialysis was performed
at 4 °C against precooled Milli-Q water (1 L) over 24 h with a water
change after 1 h. Shape transformation into nanotubes was induced by
immediate dialysis of the ﬂexible extruded polymersome solution
against a 50 mM sodium chloride solution. Filters with membrane
sizes of 200, 400, and 800 nm were used to prepare larger
polymersomes.
Loading Polymersomes with Hydrophobic and Hydrophilic
Cargos. Following the previously described method for polymersome
formation, cargo-loaded polymersomes were formed. Polymersomes
were loaded with hydrophobic cargo by initially mixing DiD with the
copolymers prior to their assembly. Together with the copolymer,
DiD was dissolved in an organic solvent mixture of dioxane and THF
(4:1 v/v) at a concentration of 0.5 mg/mL. Of this solution, 2 mL was
added to the weighed polymer, resulting in 0.5 wt % DiD with respect
to the polymer. Loading polymersomes with hydrophilic cargo was
performed by adding 1 mg/mL BSA-AF488 in Milli-Q to the polymer
solution. BSA was labeled with Alexa Fluor 488 according to the
supplier’s protocol (Supporting Information, section 1.2). Extrusion
and dialysis against Milli-Q water or 50 mM NaCl solution (to induce
tube formation) were performed as described above. After dialysis,
unincorporated BSA-AF488 and DiD were removed using size
exclusion chromatography (SEC). The eluate was concentrated
using centrifugal ﬁlters (3 kDa Amicon Ultra 0.5 mL), according to
the manufacturer’s protocol (Merck), for 30 min at 4 °C.
■ RESULTS AND DISCUSSION
According to our previous research, PEG22-PDLLA45 BCPs are
suitable for the formation of tubular polymersomes via an
osmotically induced shape transformation protocol.26 Having
synthesized the copolymer via ring-opening polymerization,
catalyzed by 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), the
composition and polydispersity were calculated from the 1H
NMR and gel permeation chromatography (GPC) data,
respectively (Đ = 1.1; Figures S1 and S2). Copolymer self-
assembly into spherical polymersomes was promoted by
addition of water (50 vol %) to a BCP solution in a
dioxane/THF mixture (4:1 v/v). PEG−PDLLA polymersomes
were subsequently dialyzed (against Milli-Q) to remove
organic solvent, resulting in rigid spherical polymersomes
with a diameter of approximately 500 nm (Figure S3a). When
the dialysis procedure was performed on the ﬂexible spherical
polymersomes with solutions of increasing salt concentration,
shape transformation into nanotubes was facilitated, with
[NaCl] = 50 mM yielding nanotubes with a length of
approximately 1 μm (Figure S3b).
This shape transformation process occurs as the polymer-
somes are exposed to hypertonic conditions, which results in
reduction of the internal volume (deﬂation), concomitant with
the minimization of the bending energy in the polymeric
membrane. Bending energy Eb can be described as a function
of three parameters, the bending rigidity k, the mean surface
curvature C, and the spontaneous curvature C0 (eq 1).
26
∮= −E k C C A2 (2 ) db 0 2 (1)
During the deﬂation of PEG−PDLLA spherical polymer-
somes, a determining factor for the formation of tubular
morphologies is the slight positive contribution of spontaneous
curvature C0 (originating from asymmetry in the copolymer
conformation between inner and outer surfaces), resulting in
the active formation of prolates (tubes).26 Interestingly, the
bending rigidity k is strongly aﬀected by the presence of
organic solvent during the shape transformation process. As
spherical polymersomes are dialyzed against water, the organic
solvent (dioxane/THF at 4:1 v/v) is slowly removed. The
signiﬁcance of the organic solvent is thermodynamically
important as it plasticizes the membrane and reduces k,
which in turn reduces Eb, so that the shape transformation can
occur (if Eb was large enough to exceed the osmotic pressure,
then no change would occur).
To develop biodegradable polymersomes with features that
are relevant for nanomedical research, achieving control over
both size and shape is of great importance. Utilizing the native
ﬂexibility of the polymersome membrane prior to dialysis, we
explored the applicability of an extrusion methodology to
facilitate greater size control in the fabrication of well-deﬁned
nanotubes with greater potential as a “precision” nanomedical
platform.
To control the size of polymersomes, the nascent dispersion
(with 50 vol % water) was extruded using diﬀerent membrane
ﬁlters (pore size 100 and 400 nm), followed by dialysis in
water. Dynamic light scattering (DLS) showed that the size of
the polymersomes decreased to about 120 (PDI ∼ 0.1) and
200 nm (PDI ∼ 0.2), respectively, compared to 550 nm
without extrusion (Figure S4). The morphology of the
polymersomes was analyzed using cryo-TEM (Figure S5).
Small monodisperse spheres of about 120 nm were observed
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for samples prepared using the 100 nm ﬁlter (Figure S5a)
whereas a more polydisperse sample was obtained with the 400
nm ﬁlter (Figure S5b), in agreement with DLS data. To induce
shape transformation, the extruded polymersomes were
dialyzed against 50 mM NaCl solution, which did not show
any remarkable change in size as compared to those dialyzed
against water, according to DLS (Figure S4b). Indeed, cryo-
TEM showed that 120 nm polymersomes did not transform
into tubes under these conditions; rather, small invaginations
were observed (Figure S5c). For the 200 nm sample, a
heterogeneous mixture of polymersomal morphologies was
observed (Figure S5d). With this in mind, it was clear that,
although well-deﬁned polymersomes of 100 nm could be
fabricated, shape transformation could not be induced. It was
hypothesized that such small polymersomes, having a much
higher surface curvature (C), would require modulation of the
conditions in order to overcome the increase in Eb that would
prohibit shape transformation.
We, thus, optimized the conditions under which extruded
polymersomes could be shape transformed, focusing on solvent
composition and ionic strength during dialysis. As the organic
solvent works as a plasticizing agent, it acts to reduce
membrane rigidity k and, thus, the bending energy. During
the assembly process, it was observed that after addition of
approximately 20 vol % of water the solution already turned
cloudy, indicating PEG−PDLLA self-assembly. This demon-
strated that it is not required to add 50 vol % of water to the
sample to induce polymersome formation, leaving us with a
window of operation between approximately 20 to 50 vol %
water for the dialysis procedure. It was found that 33 vol % of
water was the threshold for reproducible formation of stable
polymersomes. Therefore, in order to optimize the amount of
organic solvent and, consequently, membrane ﬂexibility, we
used 33 vol % of water, as opposed to the 50 vol % used under
standard conditions, for the assembly of PEG−PDLLA
polymersomes.25,26 Indeed, under these conditions, extrusion
was highly eﬀective in resizing the polymersomes from about
500 nm down to 250 (PDI ≈ 0.2) or 100 (PDI < 0.1) nm
using the 400 or 100 nm extrusion ﬁlter membranes,
respectively (Figures 2a,b and S6).
With an established protocol to fabricate polymersomes of
100 nm, a size that is highly desirable for nanomedical
applications due to favorable properties such as circulation
time and tumor penetration,1,30 we investigated the shape
transformation protocol to ﬁnd suitable conditions to generate
tubes. Osmotically induced shape transformation of PEG−
PDLLA nanotubes was attempted by dialyzing spherical
polymersomes against 50 mM NaCl at 4 °C following
extrusion.26 Although DLS did not indicate signiﬁcant changes
in Rh (Figure S6), it was clear from cryo-TEM that a structural
change had occurred in both polymersome samples (Figure
2c,d). Although shape transformation of as-prepared polymer-
somes into ≈1 μm nanotubes has been previously reported
(Figure S3), the formation of these small (≈100 nm)
nanotubes is unprecedented. Image analysis showed that
extrusion of polymersomes using a 400 nm ﬁlter yielded
structures with an average diameter of 213 nm, whereas
extrusion using a 100 nm ﬁlter resulted in polymersomes with
average diameter of 82 nm (Figure 3a,b). Shape transformation
of polymersomes extruded using 400 and 100 nm ﬁlters
resulted in nanotubes with average dimensions (length ×
width) of 630 × 85 nm and 137 × 55 nm (Figures 3c,d and
S7); their mean aspect ratios were determined at 9.8 ± 9.7 and
2.7 ± 1.5 respectively.
To investigate the eﬀect of salt on the shape transformation
of the 100 nm extruded polymersomes, four diﬀerent
concentrations were used (0, 10, 50, and 100 mM NaCl)
and analyzed using cryo-TEM (Figure 4). While for dialysis
against 0 and 10 mM NaCl spheres were observed, dialysis
against 50 or 100 mM yielded nanotubes. These results
indicate that there is a certain boundary osmotic pressure
needed to induce polymersome deﬂation. For larger polymer-
somes, we have reported that shape transformation occurs
when dialyzing against 10 mM NaCl; the necessary higher salt
concentration for the shape change process of the smaller
polymersomes is (again) a consequence of increased surface
curvature and larger Eb that needs to be overcome by the
osmotic pressure.
In addition to DLS and cryo-TEM, the polymersome
morphologies were analyzed using Asymmetric Flow Field-
Flow Fractionation (AF4) coupled with static light scattering
(MALS) and dynamic light scattering detectors (QELS). AF4
separation methods were optimized so that elution of various
polymersomes could be observed in a size-dependent fashion,
with the smallest polymersomes eluting ﬁrst (Figure 5).
Previously, we demonstrated that the combination of MALS
and QELS provides quantitative information on particle
morphology.29 From MALS data the radius of gyration (Rg)
can be determined, which is the root-mean-square radius (rms)
from the center of mass of the particle. With QELS, the
hydrodynamic radius Rh can be determined. Simultaneous
measurement of both Rg and Rh provides information on the
particle aspect ratio, as described by the shape factor ρ (=Rg/
Rh).
31 In the case of spherical particles, ρ has a value of ∼1,
while this value exceeds 1.3 for prolates (nanotubes) and
becomes larger when their aspect ratio increases. Nonextruded
polymersomes had an average ρ value of 1 (Figure S8a).
Regular nanotubes (obtained after dialysis of large polymer-
somes against 50 mM NaCl), yielded an average ρ value of 2.2,
highlighting their elongated form (Figure S8c). Extruded
polymersomes (100 nm) did not demonstrate such a marked
change in the ρ value, with only a small increase from ∼1 to
Figure 2. Cryo-TEM images of the extruded PEG22-PDLLA45
polymersomes using (a) 400 nm ﬁlter and (b) 100 nm ﬁlter, and
(c, d) following their shape transformation into elongated nanotubes
as a result of their exposure into a hypertonic shock facilitated by
dialysis (scale bar = 250 nm).
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1.2, highlighting their small aspect ratio (Figure S8b,d). This
demonstrates that AF4-MALS/QELS, along with cryo-TEM, is
a robust technique for validation of nanotubular structures.
Our results indicate that not only size, but also the aspect ratio
of biodegradable PEG−PDLLA polymersomes can be
controlled.
As the engineering of such biodegradable polymeric
architectures with discrete morphological characteristics is of
great interest to future applications in nanomedicine, it is
important to conﬁrm their stability at physiological temper-
ature. Therefore, stability was monitored using DLS before and
after 24 h of incubation in Milli-Q at 37 °C (Figure S9), which
did not indicate any changes. To further demonstrate
applicability for nanomedical applications, the possibility of
loading proteins or small molecule (model) drugs is extremely
important. In light of this, ﬂuorescently labeled proteins (BSA-
AF488) and a hydrophobic dye (DiD) were simultaneously
loaded in polymersomes during assembly. Under osmotic
shock, polymersomes loaded with either hydrophobic or
hydrophilic cargo were shape transformed into their tubular
counter parts. Nanotubes were puriﬁed using size exclusion
chromatography (Figure S10). AF4-UV-Light scattering was
used to conﬁrm the encapsulation. Polymersomes in which
BSA-AF488 was encapsulated resulted in an absorbance peak
at 488 nm, characteristic to the AF488 covalently attached to
BSA (Figure S11). Moreover, light scattering analysis of BSA-
ﬁlled (spherical) polymersomes showed a reduction of the Rg
values, yielding an average Rg/Rh of 0.77 ± 0.09 (Figure S12),
indicating the presence of BSA inside the polymersomes.32
Confocal microscopy and ﬂuorescence spectroscopy conﬁrmed
successful loading of both dyes (Figure 6), although
determination of colocalization was challenging due to the
fast Brownian motion of the small polymersomes.
■ CONCLUSION
In summary, we have developed a robust methodology to
generate small-sized biodegradable polymersomes through
extrusion. By ﬁne-tuning of the self-assembly, extrusion and
shape transformation processes, tubular polymersomes with a
size of approximately 100 nm were prepared. Such control over
morphological characteristics is highly desirable for nano-
medical applications such as therapeutic drug delivery and for
speciﬁc manipulation of immune responses to battle cancer or
autoimmune disease. Uncovering the physical basis of the
underlying mechanism of shape transformation provided a
Figure 3. Histogram analysis of cryo-TEM data of extruded spherical polymersomes using (a) 400 and (b) 100 nm ﬁlters, and (c, d) after their
shape transformation into nanotubes.
Figure 4. Salt concentration is essential for eﬀective shape
transformation of extruded polymersome spheres of ∼100 nm into
nanotubes. Cryo-TEM analysis shows that dialysis in 10 mM NaCl is
not suﬃcient to induce a shape-transformation, whereas tubular
structures are formed when prepared with 50 and 100 mM NaCl.
Increasing NaCl concentration from 50 to 100 mM does not result in
any notable further elongation of the nanotubes. Scale bar = 100 nm.
Figure 5. AF4-MALS-QELS shows diﬀerent elution times of extruded
polymersomes and their corresponding nanotubes.
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direction on how such a well-controlled shape transformation
of small polymersomes (with high bending energy) could be
achieved. Moreover, we showed the possibility to load the
resulting nanotubes with hydrophilic and hydrophobic cargoes,
an important development of this system toward biomedical
applications.
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